Approval · Notice of Compliance 1633 · 2004
PENLAC: Notice of Compliance 1633
Issued April 19, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1633
- Date
- April 19, 2004
- Company
- Dermik Laboratories Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Topical antifungal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PENLAC | 02250535 | Dormant |
Medicinal ingredients
- CICLOPIROX 80 MG per G